Anni Morsing

Anni Morsing currently serves as the Senior Director of Clinical Development Lead Radio-Diagnostics at Curium Pharma, a position held since November 2022. Prior to this role, Anni Morsing was the Medical Director at YmAbs Therapeutics, Inc. from January 2022 to November 2022, and held multiple positions at Novo Nordisk from June 2019 to January 2022, including Senior Director and International Medical Director. Anni Morsing's earlier experience includes consulting roles at Odense University Hospital and various departments within Rigshospitalet from 2016 to 2020, and leadership as Head of Department and Senior Consultant at Aarhus University Hospital from 2009 to 2016. Anni Morsing is also recognized for holding the presidency of the Danish Society of Clinical Physiology and Nuclear Medicine from September 2014 to September 2016. Anni Morsing possesses advanced degrees in medicine, including an MD, PhD, and DMSc from Aarhus University.